It has an agreement with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products. The company operates in Eastern Europe, the Middle East, Africa ...

Celerity has secured £15m in investment from Business Growth Fund (BGF), with CEO Chris Roche claiming that now is the "perfect time" for the MSP to supercharge its growth strategy. Founded in 2002, ...